• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Differences in US healthcare coverage policies in BRCA testing and potential implications.

作者信息

Beattie Mary S, Wang Grace, Phillips Kathryn A

机构信息

University of California, San Francisco, 1635 Divisadero St, Suite 600, San Francisco, CA 94115, USA.

Center for Translational & Policy Research on Personalized Medicine (TRANSPERS), University of California, San Francisco, 3333 California St, Suite 420, Box 613, San Francisco, CA 94118, USA.

出版信息

Per Med. 2012 Jan;9(1):5-8. doi: 10.2217/pme.11.85.

DOI:10.2217/pme.11.85
PMID:29783285
Abstract
摘要

相似文献

1
Differences in US healthcare coverage policies in BRCA testing and potential implications.美国BRCA检测中医疗保健覆盖政策的差异及潜在影响。
Per Med. 2012 Jan;9(1):5-8. doi: 10.2217/pme.11.85.
2
Disparities in BRCA testing: when insurance coverage is not a barrier.BRCA检测中的差异：当保险覆盖范围不是障碍时。
Am J Surg. 2009 Oct;198(4):562-5. doi: 10.1016/j.amjsurg.2009.07.003.
3
4
The role of financial factors in acceptance of clinical BRCA genetic testing.财务因素在临床BRCA基因检测接受度中的作用。
Genet Test. 2007 Spring;11(1):101-10. doi: 10.1089/gte.2006.9999.
5
Genetic testing insurance coverage trends: a review of publicly available policies from the largest US payers.基因检测保险覆盖趋势：对美国最大支付方公开政策的综述
Per Med. 2013 May;10(3):235-243. doi: 10.2217/pme.13.9.
6
Hereditary breast and ovarian cancer syndrome: considering the complexities.
Curr Probl Cancer. 2014 Nov-Dec;38(6):226-34. doi: 10.1016/j.currproblcancer.2014.10.003. Epub 2014 Oct 31.
7
"It's not if I get cancer, it's when I get cancer": BRCA-positive patients' (un)certain health experiences regarding hereditary breast and ovarian cancer risk.“不是我是否会患癌症，而是我何时会患癌症”：BRCA基因呈阳性的患者关于遗传性乳腺癌和卵巢癌风险的（不）确定健康经历。
Soc Sci Med. 2016 Aug;163:21-7. doi: 10.1016/j.socscimed.2016.06.039. Epub 2016 Jun 23.
8
Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families.遗传性乳腺癌-卵巢癌家族中患者对BRCA基因突变检测结果披露的反应。
Cancer Genet Cytogenet. 2006 Mar;165(2):91-7. doi: 10.1016/j.cancergencyto.2005.07.011.
9
BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk.BRCA基因突变增加遗传性乳腺癌/卵巢癌风险家族的生育能力。
PLoS One. 2015 Jun 5;10(6):e0127363. doi: 10.1371/journal.pone.0127363. eCollection 2015.
10
What would you do? Specialists' perspectives on cancer genetic testing, prophylactic surgery, and insurance discrimination.你会怎么做？专家对癌症基因检测、预防性手术及保险歧视的看法。
J Clin Oncol. 2000 Jun;18(12):2484-92. doi: 10.1200/JCO.2000.18.12.2484.

引用本文的文献

1
Research to reduce inequities in cancer risk services: Insights for remote genetic counseling in a pandemic and beyond.减少癌症风险服务不平等现象的研究：大流行及以后远程遗传咨询的见解
J Genet Couns. 2021 Oct;30(5):1292-1297. doi: 10.1002/jgc4.1525. Epub 2021 Oct 23.
2
Application of Economic Evaluation to Assess Feasibility for Reimbursement of Genomic Testing as Part of Personalized Medicine Interventions.应用经济评估来评估作为个性化医疗干预一部分的基因检测报销的可行性。
Front Pharmacol. 2019 Aug 2;10:830. doi: 10.3389/fphar.2019.00830. eCollection 2019.
3
Personalizing health care: feasibility and future implications.
个性化医疗保健：可行性及未来影响。
BMC Med. 2013 Aug 13;11:179. doi: 10.1186/1741-7015-11-179.